RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,284 | -32.0% | 22,507 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $278,342 | -25.8% | 22,161 | -2.7% | 0.00% | -33.3% |
| Q1 2023 | $375,005 | +13.8% | 22,769 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $329,427 | -16.8% | 22,050 | +24.5% | 0.00% | -25.0% |
| Q3 2022 | $396,000 | +34.2% | 17,717 | +0.6% | 0.00% | +33.3% |
| Q2 2022 | $295,000 | -15.7% | 17,606 | +50.7% | 0.00% | 0.0% |
| Q1 2022 | $350,000 | 0.0% | 11,682 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $350,000 | +25.9% | 11,401 | +29.5% | 0.00% | +50.0% |
| Q3 2021 | $278,000 | -11.7% | 8,807 | +2.4% | 0.00% | -33.3% |
| Q2 2021 | $315,000 | +15.8% | 8,601 | +9.5% | 0.00% | +50.0% |
| Q1 2021 | $272,000 | -16.3% | 7,858 | +0.4% | 0.00% | -33.3% |
| Q4 2020 | $325,000 | – | 7,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |